September 18, 2018 / 12:29 PM / a month ago

BUZZ-Tilray: U.S. approves import of cannabis drug for trial

** Shares of cannabis maker Tilray Inc rise ~10 percent to $132.29 premarket; set to post 2nd session of gains, which would add ~20 pct to stock’s value

** U.S. regulator approve import Tilray’s cannabis study drug in the U.S. from Canada for a clinical study

** The cannabis-infused pill aims to treat a form of nerve disorder, trials are expected begin in early 2019 - TLRY

** Other marijuana stocks also rise: Canopy Growth Corp 2.6 pct, Cronos Group Inc 1.7 pct

** TLRY’s stock has risen more than four-fold YTD (Reporting by John Benny in Bengaluru)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below